The recent milestone publication by Schmauch et al. in Nature (650 (2026): 205-217) describes a 61-day longitudinal multi-omics analysis of a gene-edited pig-to-human kidney xenotransplant in a brain-dead decedent. This study provides an unprecedented high-resolution map of the xenogeneic immune response. In this commentary, we move beyond summary to interpret these findings through a clinical transplant lens, contrasting xenograft rejection with established experience in human renal allografts. This comparison highlights practice-relevant differences in immune hierarchy, rejection chronology, and the dominant contribution of innate and humoral immunity. Recognizing these differences-moving from the "civil war" of allotransplantation to the "interspecies conflict" of xenotransplantation-will be essential for designing first-in-human trials, tailoring immunosuppressive regimens, and building rational monitoring strategies as the field advances toward living recipients.
Liu et al. (Sun,) studied this question.